Jacobs was selected for this project phase following the successful completion of the conceptual study and basic engineering design
As Ferring Pharmaceuticals’ principal biopharmaceutical product development center, this new facility will feature collaborative work spaces and serve as an inspirational, global Research & Development unit for identifying and developing innovative products in the fields of reproductive health, urology, gastroenterology, endocrinology and orthopedics.
When constructed, the facility will include six stories above grade, two basement levels, and a site area of approximately 124,000 square feet (11,500 square meters). Jacobs is working alongside Foster + Partners, an architecture consultancy firm, to develop the iconic vision for the new R&D center.
“Our clients turn to Jacobs because we provide the biopharmaceutical labs and corporate building expertise they need, as well as end-to-end solutions for delivering their facility to completion,” said Jacobs Buildings & Infrastructure and Industrial President Bob Pragada.
Jacobs is one of the world’s largest and most diverse providers of full-spectrum technical, professional and construction services for industrial, commercial and government organizations globally.